Locally advanced non-small cell lung cancer in 2019: novel diagnostic and therapeutic strategies to tackle complex stage III disease

Symposium
Chairs: R. Huber (Munich, Germany), E. Ruffini (Torino (TO), Italy)
Aims: to enhance understanding of differential treatment algorithms for definitive radiochemotherapy or resection in combination with systemic therapy (and radiotherapy) in patients with locally advanced non-small cell lung cancer (NSCLC); to discuss the new options of targeted therapy and immunotherapy in this potentially curative setting.

Diagnostic work-up in stage III NSCLC including assessment of fitness for radical therapy J. van den Aardweg (Heemstede, Netherlands)
Modern radiotherapy as a curative treatment modality for stage III NSCLC E. Troost (Dresden, Germany)
Prerequisites, potential and limits of thoracic surgery with curative intent for stage III NSCLC D. Waller (London, United Kingdom)